Inulin Improves Diet-Induced Hepatic Steatosis and Increases Intestinal Akkermansia Genus Level

Int J Mol Sci. 2022 Jan 17;23(2):991. doi: 10.3390/ijms23020991.

Abstract

Hepatic steatosis is characterized by triglyceride accumulation within hepatocytes in response to a high calorie intake, and it may be related to intestinal microbiota disturbances. The prebiotic inulin is a naturally occurring polysaccharide with a high dietary fiber content. Here, we evaluate the effect of inulin on the intestinal microbiota in a non-alcoholic fatty liver disease model. Mice exposed to a standard rodent diet or a fat-enriched diet, were supplemented or not, with inulin. Liver histology was evaluated with oil red O and H&E staining and the intestinal microbiota was determined in mice fecal samples by 16S rRNA sequencing. Inulin treatment effectively prevents liver steatosis in the fat-enriched diet group. We also observed that inulin re-shaped the intestinal microbiota at the phylum level, were Verrucomicrobia genus significantly increased in the fat-diet group; specifically, we observed that Akkermansia muciniphila increased by 5-fold with inulin supplementation. The family Prevotellaceae was also significantly increased in the fat-diet group. Overall, we propose that inulin supplementation in liver steatosis-affected animals, promotes a remodeling in the intestinal microbiota composition, which might regulate lipid metabolism, thus contributing to tackling liver steatosis.

Keywords: A. muciniphila; hepatic steatosis; intestinal microbiota; inulin; prebiotics.

MeSH terms

  • Akkermansia / classification*
  • Akkermansia / genetics
  • Akkermansia / isolation & purification
  • Animals
  • DNA, Bacterial / genetics
  • DNA, Ribosomal / genetics
  • Diet, High-Fat / adverse effects*
  • Gastrointestinal Microbiome / drug effects
  • High-Throughput Nucleotide Sequencing
  • Inulin / administration & dosage*
  • Inulin / pharmacology
  • Lipid Metabolism / drug effects
  • Male
  • Mice
  • Non-alcoholic Fatty Liver Disease / chemically induced
  • Non-alcoholic Fatty Liver Disease / drug therapy*
  • Non-alcoholic Fatty Liver Disease / microbiology
  • Phylogeny
  • RNA, Ribosomal, 16S / genetics
  • Sequence Analysis, DNA / methods*

Substances

  • DNA, Bacterial
  • DNA, Ribosomal
  • RNA, Ribosomal, 16S
  • Inulin